NeuroBo Pharmaceuticals Stock Gains 5%

Shares of NeuroBo Pharmaceuticals, Inc. (NRBO) are gaining nearly 5% on Thursday morning despite no stock-related news to drive the shares.

NRBO is currently trading at $16.40, up $0.73 or 4.66%, on the Nasdaq. The stock opened its trading at $17.70 after closing Wednesday's trading at $15.67. The stock has traded between $7.41 and $123.42 in the past 52-week period.

NeuroBo Pharmaceuticals is a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Follow RTT